FPR2 and myocardial infarction: BMS-986235—an FPR2/ALX agonist—demonstrated cardioprotection in murine and rat models of myocardial infarction induced by permanent LAD ligation, reducing infarct size, preserving left-ventricular systolic function, and attenuating adverse remodeling [140].